| Nursing mothers and women who are pregnant should avoid Coenzyme Q10 supplements due to a
lack of long-term safety studies. There is a report of Coenzyme Q10 decreasing the
effectiveness of warfarin. Clinical reports from Japan suggest that supplemental Coenzyme
Q10 might improve beta-cell function and glycemic control in type II diabetics. Coenzyme Q10
doesn't appear to improve glycemic control in type I diabetics. Diabetics should know of
this possibility, and diabetics who do use supplemental Coenzyme Q10 should determine if
they need to make any adjustments in their diabetic medications. Mild gastrointestinal
symptoms such asdiarrhea, epigastric distress, and nausea have been reported, particularly
with higher doses. Coenzyme Q10 and cholesterol share the same metabolic pathways.
Inhibition of the enzyme 3-hydroxyl-3-methylglutonyl coenzyme A (HMG-CoA) reductase would be
expected to decrease Coenzyme Q10 levels. The statin medicines lovastatin, pravastatin, and
simvastatin are known to decrease Coenzyme Q10 levels in people. It's likely that all
statins have this effect. Coenzyme Q10 might help to ameliorate the cardiotoxicity of
doxorubicin. Some beta blockers, in particular propanolol, have been reported to inhibit
some Coenzyme Q10 dependent enzymes. Piperine may increase plasma levels of Coenzyme Q10.
This website is intended to educate and inform, and should not replace discussions with
your doctor. |